Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic
Top Cited Papers
Open Access
- 1 October 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (4) , 1104-1107
- https://doi.org/10.1086/318121
Abstract
In India, 320 patients with visceral leishmaniasis (209 in the state of Bihar and 11 in the neighboring state of Uttar Pradesh) received identical peKeywords
This publication has 13 references indexed in Scilit:
- LeishmaniasisThe Lancet, 1999
- Oral treatment of visceral leishmaniasis with miltefosinePathogens and Global Health, 1999
- Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovaniThe Journal of Infectious Diseases, 1999
- U.S. Food and Drug Administration Approval of AmBisome (Liposomal Amphotericin B) for Treatment of Visceral LeishmaniasisClinical Infectious Diseases, 1999
- Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin B-lipid complexPathogens and Global Health, 1998
- Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first line drug? An observational study of 80 casesPathogens and Global Health, 1998
- Response to Interferon‐γ plus Pentavalent Antimony in Indian Visceral LeishmaniasisThe Journal of Infectious Diseases, 1997
- Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 YearsClinical Infectious Diseases, 1997
- Clinicoepidemiological study of drug resistance in Indian kala - azarBMJ, 1994
- Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical StudiesThe American Journal of Tropical Medicine and Hygiene, 1992